Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D04FFS
|
||||
| Former ID |
DNC010421
|
||||
| Drug Name |
Benzaldehyde O-4-(pentyloxy)phenylcarbamoyl oxime
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [530604] | ||
| Formula |
C19H22N2O3
|
||||
| Canonical SMILES |
CCCCCOC1=CC=C(C=C1)NC(=O)ON=CC2=CC=CC=C2
|
||||
| InChI |
1S/C19H22N2O3/c1-2-3-7-14-23-18-12-10-17(11-13-18)21-19(22)24-20-15-16-8-5-4-6-9-16/h4-6,8-13,15H,2-3,7,14H2,1H3,(H,21,22)/b20-15+
|
||||
| InChIKey |
RMGKIVHTNJBERM-HMMYKYKNSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Fatty-acid amide hydrolase | Target Info | Inhibitor | [530604] | |
| BioCyc Pathway | Anandamide degradation | ||||
| KEGG Pathway | Retrograde endocannabinoid signaling | ||||
| PANTHER Pathway | Anandamide degradation | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.